)

Sun Pharmaceutical Industries (SUNPHARMA) investor relations material
Sun Pharmaceutical Industries Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q1 FY26 sales reached INR 137,861 million, up 10.1% year-over-year, with strong growth in India and emerging markets, and continued momentum in innovative medicines.
EBITDA grew 19.2% year-over-year to INR 43,017 million, with margin at 31.1%, driven by favorable product mix and higher specialty sales.
Adjusted net profit rose 5.7% to INR 29,961 million; reported net profit was INR 22,786 million after exceptional items.
India formulation sales grew 13.9% year-over-year, outpacing the market, led by volume and new launches.
Global innovative medicines sales climbed 16.9% to $311 million, now 19.3% of total sales.
Financial highlights
Gross margin improved due to lower material costs and higher innovative medicines share.
Exceptional items of INR 8,180 million included SCD044 impairment and GSMDL settlement.
Forex gain of INR 2,290 million versus a loss last year; other income lower due to prior year tax refund.
Net cash position at $3.1 billion, invested in approved securities for future investments.
Adjusted EPS for the quarter was INR 12.5.
Outlook and guidance
Plan to file for ILUMYA psoriatic arthritis indication by year-end; expect U.S. launch of Unloxit in H2 FY26.
R&D spend guidance maintained; higher promotional expenses for new launches expected to be sustained through the year.
Effective tax rate expected around 25% for the full year.
Continued investment in R&D and pipeline development, with six novel entities in clinical stage.
Management highlighted strong performance and steady progress across all markets, with India and US launches driving growth.
Next Sun Pharmaceutical Industries earnings date

Next Sun Pharmaceutical Industries earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage